NCT03612960View on ClinicalTrials.gov

Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

February 20, 2020

Primary Completion Date

June 23, 2023

Study Completion Date

June 23, 2023

Conditions
Tobacco Dependence
Interventions
DRUG

Very low nicotine content cigarettes

Very low nicotine content cigarettes

DRUG

Normal nicotine content cigarettes

Normal nicotine content cigarettes

Trial Locations (1)

17033

Penn State Health, Hershey

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Milton S. Hershey Medical Center

OTHER

NCT03612960 - Measuring Neuroadaptations in Response to Very Low Nicotine Content Cigarettes | Biotech Hunter | Biotech Hunter